TY  - CHAP
M1  - Book, Section
TI  - Perioperative Management of Endocrine Diseases
A1  - Cheng, Hugo Q.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - The  goal  of  management  for  all  diabetic  patients  is  the  prevention  of  severe  hyper-  or  hypoglycemia  in  the  perioperative  period.  In  addition,  patients  with  type  1  diabetes  are  at  risk  for  developing  ketoacidosis.  Increased  secretion  of  cortisol,  epinephrine,  glucagon,  and  growth  hormone  during  and  after  surgery  causes  insulin  resistance  and  hyperglycemia  in  diabetic  patients.  Conversely,  reduced  caloric  intake  after  surgery  and  frequent,  unpredictable  periods  of  fasting  increase  the  risk  for  hypoglycemia.  Thus,  all  surgical  diabetic  patients  require  frequent  blood  glucose  monitoring.  Ideally,  patients  with  diabetes  should  undergo  surgery  early  in  the  morning.  The  specific  pharmacologic  management  of  diabetes  during  the  perioperative  period  depends  on  the  type  of  diabetes  (insulin-dependent  or  not),  the  level  of  glycemic  control,  and  the  type  and  length  of  surgery.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193124480
ER  -